3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

Table 2 Cisplatin Dose Intensity

	3-weekly Cisplatin	Weekly Cisplatin	p-value
Median cumulative cisplatin dose	200 mg/m²	160 mg/m²	< 0.001
Cumulative dose ≥200 mg²	96 (75.6%)	88 (47.1%)	< 0.001
Dose reduction	6 (4.7%)	11 (5.8%)
Change to other chemotherapy	33 (25.9%)	35 (18.7%)

ISSN: 1748-717X